The old saying, “you cannot be too rich or too thin” will prove popular as a new diet pill has proven safe and is expected to obtain FDA approval.
With the release of the pill Lorcaserin, users will get thinner and Arena Pharmaceuticals, the drug manufacturer and their investors will get richer.
Arena’s stock has already begun to soar.
The now experimental diet pill has proven effective in a two year trial that included nearly 3200 participants.
The only noted side effects were headaches and dizziness, according to a study in the New England Journal of Medicine.
There were no issues of the heart maladies that caused the once accepted fen-phen pills to be removed from the market.
Lorcaserin appears to be a similar, but safer product that is expected to be approved by the FDA.
For tips, story ideas or other breaking news, send an e-mail to stocktonheadlines@gmail.com.
If you would like to be notified via email when headline articles are published, click "Subscribe" on the tab at the top of this article.
Feel free to leave readers comments.











Comments